Queensland University of Technology (QUT) and the University of Queensland (UQ) scientists have developed a new technique to study how some common disease-causing pathogens can spread up to 4m and remain alive in the air for up to 45 minutes.
The simple, well-worn advice for preventing winter colds and flu from spreading has been strengthened with new research from a team of researchers from QUT, led by professor Lidia Morawska, director of the International Laboratory for Air Quality and Health and professor Scott Bell from QIMR Berghofer Medical Research Institute and The Prince Charles Hospital.
Morawska said the research was possibly one of the first to study the longevity of airborne pseudomonas aeruginosa bacteria, a multi-drug resistant germ associated with hospital-acquired infections, when they are expelled by human coughs and sneezes.
"Our previous research had found that these pathogens travelled up to 4m and stayed viable for 45 minutes after being coughed into the air," Morawska said. "We wanted to find out how far bacteria-carrying droplets expelled by sneezes or coughs travel such distances and remain able to infect other people after such a long time. Most research in this area to date has focused on laboratory-generated bio-aerosols, or airborne droplets, which are different from natural respiratory droplets generated by humans in composition and mechanisms of production. We developed a novel technique to target the short-term and long-term ageing of bio-aerosols from people, without contamination from the ambient air. To demonstrate the technique, airborne cough droplets were sampled from two patients with cystic fibrosis and chronic pseudomonas aeruginosa infection."
Morawska said the research team found that the bacteria in the cough droplets from the patients decayed in two different time spans.
"As soon as cough droplets hit the air they rapidly dry out, cool and become light enough to stay airborne. They also partly degrade through contact with oxygen in the air, with larger droplets taking much longer to evaporate. We found that the concentration of active bacteria in the dried droplets showed rapid decay with a 10-second half-life for most of the bacteria but a subset of bacteria had a half-life of more than 10 minutes," she said. "This suggests some of the pseudomonas aeruginosa bacteria are resistant to rapid biological decay and thus remain viable in room air long enough to form an airborne infection risk, especially to people with respiratory problems such as patients with cystic fibrosis. We think this could be because droplets are produced in different parts of the respiratory tract and carry different 'loads' of bacteria. The larger droplets carrying bacteria take longer to evaporate which makes them more resistant to decay and able to maintain bacteria viability for extended periods."
Morawska said the findings had implications for infection control in hospitals and particularly with the treatment of people with cystic fibrosis.
Source: Queensland University of Technology
Understanding the True Threat: Richard Webby, PhD, on H5N1 Avian Flu and Its Human Impact
January 3rd 2025Richard Webby, PhD, the director of the World Health Organization (WHO) Collaborating Centre or Studies on the Ecology of Influenza in Animals and Birds, discusses the evolving dynamics of H5N1 avian flu, its variants, and the low risk to humans while emphasizing vigilance among health care professionals.
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.